piperidine N,N-dimethylformamide → Benzyl Nepsilon-(t-butoxycarbonyl)-L-lysine
Reaction equation
[CH2:1]([N:8](C(OCC1C2C=CC=CC=2C2C1=CC=CC=2)=O)[C@H:9]([C:22]([OH:24])=[O:23])[CH2:10][CH2:11][CH2:12][CH2:13][NH:14][C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.N1CCCCC1.CN(C=O)C>>[CH2:1]([NH:8][C@H:9]([C:22]([OH:24])=[O:23])[CH2:10][CH2:11][CH2:12][CH2:13][NH:14][C:15]([O:17][C:18]([CH3:20])([CH3:21])[CH3:19])=[O:16])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
3
Procedure
Fmoc protected amino acid 48 (1.0 g, 1.79 mmol) was treated with a solution of piperidine/DMF (9 mL, 5% v/v) and stirred for 20 min then concentrated to dryness and used directly in the next step.
Workup
- concentrationthen concentrated to dryness
Sources & evidence
- ORD record
- ord-187bc8e3b64342b29a9ed6fc5110722e
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901072B2
Reaction notes
Loading…